Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity-Reference-Cited by-同舟云学术

Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity

Published:2021-06-30 Issue:7866 Volume:595 Page:289-294
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Mwakingwe-Omari Agnes,Healy Sara A.^ORCID,Lane Jacquelyn,Cook David M.,Kalhori Sahand,Wyatt Charles,Kolluri Aarti,Marte-Salcedo Omely,Imeru Alemush,Nason Martha^ORCID,Ding Lei K.,Decederfelt Hope,Duan Junhui,Neal Jillian,Raiten Jacob,Lee Grace,Hume Jen C. C.,Jeon Jihyun E.,Ikpeama Ijeoma,KC Natasha,Chakravarty Sumana,Murshedkar Tooba,Church L. W. Preston,Manoj Anita,Gunasekera Anusha,Anderson Charles,Murphy Sean C.^ORCID,March Sandra,Bhatia Sangeeta N.^ORCID,James Eric R.,Billingsley Peter F.,Sim B. Kim Lee,Richie Thomas L.^ORCID,Zaidi Irfan,Hoffman Stephen L.,Duffy Patrick E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-021-03684-z.pdf

Reference51 articles.

1. WHO. World Malaria Report 2019 (World Health Organization, 2019).

2. The RTS,S Clinical Trials Partnership. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 11, e1001685 (2014).

3. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31–45 (2015).

4. The RTS,S Clinical Trials Partnership. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367, 2284–2295 (2012).

5. Epstein, J. E. et al. Protection against Plasmodium falciparum malaria by PfSPZ vaccine. JCI Insight 2, e89154 (2017).

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5;Cell;2024-09

2. Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials;The Lancet Infectious Diseases;2024-08

3. Malaria vaccines: a new era of prevention and control;Nature Reviews Microbiology;2024-07-18

4. Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms;Nature Communications;2024-06-18

5. Vaccines and monoclonal antibodies: new tools for malaria control;Clinical Microbiology Reviews;2024-06-13